Microbiome Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 101.20%
- Profit Growth 1731.66%
- Ebitda 347.22%
- Net Worth 220.57%
- Total Assets 108.73%
About Microbiome Research
Microbiome Research Private Limited (MRPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2016 (Eight years and 11 months 26 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ravi Shroff, Hrishit Shroff, and Chaitanya Shroff serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74120MH2016PTC272806
-
Company No.
272806
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Microbiome Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Shroff
|
Director | 06-Feb-2016 | Current |
|
Hrishit Shroff
|
Director | 06-Feb-2016 | Current |
|
Chaitanya Shroff
|
Director | 06-Feb-2016 | Current |
Financial Performance of Microbiome Research.
Microbiome Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 101.2% increase. The company also saw a substantial improvement in profitability, with a 1731.66% increase in profit. The company's net worth Soared by an impressive increase of 220.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Microbiome Research?
In 2023, Microbiome Research had a public holding of 8.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Silox India Private LimitedRavi Shroff is a mutual person
-
Tml Industries LimitedRavi Shroff is a mutual person
-
Maxeema Bio-Tech Private LimitedChaitanya Shroff is a mutual person
-
Mibiome Therapeutics LlpRavi Shroff is a mutual person
-
Excel Industries LimitedRavi Shroff and Hrishit Shroff are mutual person
-
Excel Bio Resources LimitedRavi Shroff and Hrishit Shroff are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Microbiome Research?
Unlock and access historical data on people associated with Microbiome Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Microbiome Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Microbiome Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
